The	O
transcription	B-protein
factor	I-protein
,	O
Nm23H2	B-protein
,	O
binds	O
to	O
and	O
activates	O
the	O
translocated	O
c-myc	B-DNA
allele	I-DNA
in	O
Burkitt	O
's	O
lymphoma	O
.	O

We	O
have	O
identified	O
an	O
in	O
vivo	O
footprint	O
over	O
the	O
PuF	B-DNA
site	I-DNA
on	O
the	O
translocated	O
c-myc	B-DNA
allele	I-DNA
in	O
Burkitt	O
's	O
lymphoma	O
cells	O
.	O

The	O
PuF	B-DNA
site	I-DNA
on	O
the	O
silent	B-DNA
normal	I-DNA
c-myc	I-DNA
allele	I-DNA
was	O
unoccupied	O
.	O

We	O
demonstrated	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
electrophoretic	O
mobility	O
shift	O
assay	O
with	O
antibody	O
,	O
UV	O
cross-linking	O
followed	O
by	O
SDS-gel	O
electrophoresis	O
,	O
and	O
Western	O
analysis	O
that	O
Nm23H2	B-protein
in	O
B	O
cell	O
nuclear	O
extracts	O
bound	O
to	O
the	O
c-myc	O
PuF	B-DNA
site	I-DNA
.	O

Transfection	O
experiments	O
with	O
c-myc	B-DNA
promoter	I-DNA
constructs	I-DNA
in	O
both	O
DHL-9	B-cell_line
and	O
Raji	B-cell_line
cells	I-cell_line
revealed	O
that	O
the	O
PuF	B-DNA
site	I-DNA
functioned	O
as	O
a	O
positive	B-DNA
regulatory	I-DNA
element	I-DNA
in	O
B	B-cell_type
cells	I-cell_type
with	O
a	O
drop	O
in	O
activity	O
with	O
mutation	O
of	O
this	O
site	O
.	O

Access	O
to	O
this	O
site	O
is	O
blocked	O
in	O
the	O
normal	B-DNA
silent	I-DNA
c-myc	I-DNA
allele	I-DNA
;	O
these	O
data	O
suggest	O
that	O
the	O
Nm23H2	B-protein
protein	O
is	O
involved	O
in	O
deregulation	O
of	O
the	O
translocated	O
c-myc	B-DNA
allele	I-DNA
in	O
Burkitt	B-cell_line
's	I-cell_line
lymphoma	I-cell_line
cells	I-cell_line
.	O

THE	NULL
JOURNAL	NULL
OF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

22	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
2	NULL
,	NULL
pp	NULL
.	NULL

13392-13398	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Transcription	NULL
Factor	NULL
,	NULL
Nm23H2	NULL
,	NULL
Binds	NULL
to	NULL
and	NULL
Activates	NULL
the	NULL
Translocated	NULL
ec-mye	NULL
Allele	NULL
in	NULL
Burkitt	NULL
's	NULL
Lymphoma*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
17	NULL
,	NULL
1995	NULL
)	NULL
Lin	NULL
Ji	NULL
,	NULL
Magdalena	NULL
Arcinas	NULL
,	NULL
and	NULL
Linda	NULL
M.	NULL
Boxer	NULL
?	NULL

From	NULL
the	NULL
Center	NULL
for	NULL
Molecular	NULL
Biology	NULL
in	NULL
Medicine	NULL
,	NULL
VAMC	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
California	NULL
94304	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
We	NULL
have	NULL
identified	NULL
an	NULL
in	NULL
vivo	NULL
footprint	NULL
over	NULL
the	NULL
PuF	NULL
site	NULL
on	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

The	NULL
PuF	NULL
site	NULL
on	NULL
the	NULL
silent	NULL
normal	NULL
e-mye	NULL
allele	NULL
was	NULL
unoccupied	NULL
.	NULL

We	NULL
demonstrated	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
antibody	NULL
,	NULL
UV	NULL
cross-linking	NULL
followed	NULL
by	NULL
SDS-gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
Western	NULL
analysis	NULL
that	NULL
Nm23H2	NULL
in	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
bound	NULL
to	NULL
the	NULL
e-mye	NULL
PuF	NULL
site	NULL
.	NULL

Transfection	NULL
experiments	NULL
with	NULL
c-mye	NULL
promoter	NULL
constructs	NULL
in	NULL
both	NULL
DHL-9	NULL
and	NULL
Raji	NULL
cells	NULL
revealed	NULL
that	NULL
the	NULL
PuF	NULL
site	NULL
functioned	NULL
as	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
drop	NULL
in	NULL
activity	NULL
with	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
,	NULL
Access	NULL
to	NULL
this	NULL
site	NULL
is	NULL
blocked	NULL
in	NULL
the	NULL
normal	NULL
silent	NULL
c-myc	NULL
allele	NULL
;	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
Nm23H2	NULL
protein	NULL
is	NULL
involved	NULL
in	NULL
deregulation	NULL
of	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

In	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
,	NULL
one	NULL
c-myc	NULL
allele	NULL
is	NULL
juxtaposed	NULL
to	NULL
either	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
locus	NULL
or	NULL
to	NULL
one	NULL
of	NULL
the	NULL
light	NULL
chain	NULL
loci	NULL
.	NULL

The	NULL
translocated	NULL
c-myc	NULL
gene	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
,	NULL
while	NULL
the	NULL
normal	NULL
c-myc	NULL
allele	NULL
is	NULL
silent	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

In	NULL
all	NULL
of	NULL
the	NULL
cases	NULL
with	NULL
an	NULL
intact	NULL
e-mye	NULL
transcription	NULL
unit	NULL
,	NULL
there	NULL
are	NULL
structural	NULL
alterations	NULL
at	NULL
the	NULL
first	NULL
exon/intron	NULL
boundary	NULL
(	NULL
5-8	NULL
)	NULL
,	NULL
and	NULL
c-myc	NULL
transcription	NULL
initiates	NULL
preferentially	NULL
at	NULL
promoter	NULL
P1	NULL
in	NULL
contrast	NULL
to	NULL
normal	NULL
cells	NULL
in	NULL
which	NULL
the	NULL
P2	NULL
promoter	NULL
is	NULL
the	NULL
major	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
block	NULL
to	NULL
RNA	NULL
elongation	NULL
is	NULL
not	NULL
present	NULL
in	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

The	NULL
deregulated	NULL
c-mye	NULL
gene	NULL
is	NULL
believed	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Transgenic	NULL
mice	NULL
that	NULL
carried	NULL
the	NULL
c-myc	NULL
gene	NULL
linked	NULL
to	NULL
the	NULL
immunoglobulin	NULL
intron	NULL
enhancer	NULL
developed	NULL
B	NULL
cell	NULL
malignancies	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
when	NULL
lymphoblastoid	NULL
cells	NULL
immortalized	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
constitutively	NULL
expressed	NULL
c-myc	NULL
gene	NULL
,	NULL
the	NULL
cells	NULL
became	NULL
tumorigenic	NULL
in	NULL
nude	NULL
mice	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
of	NULL
the	NULL
deregulation	NULL
of	NULL
the	NULL
translocated	NULL
c-myc	NULL
gene	NULL
is	NULL
unknown	NULL
,	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
immunoglobulin	NULL
locus	NULL
may	NULL
play	NULL
a	NULL
role	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

We	NULL
are	NULL
studying	NULL
the	NULL
interplay	NULL
between	NULL
the	NULL
c-myc	NULL
and	NULL
immunoglobulin	NULL
regulatory	NULL
elements	NULL
,	NULL
and	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
two	NULL
NF-kB	NULL
sites	NULL
in	NULL
the	NULL
c-myc	NULL
gene	NULL
that	NULL
are	NULL
occupied	NULL
only	NULL
on	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
characterize	NULL
the	NULL
role	NULL
of	NULL
the	NULL
Nm23H2	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA34233	NULL
and	NULL
CA56764	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Veterans	NULL
Affairs	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Division	NULL
of	NULL
Hema-tology	NULL
,	NULL
S-161	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94305-5112	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
415-493-5000	NULL
(	NULL
ext	NULL
.	NULL

3126	NULL
)	NULL
;	NULL
Fax	NULL
:	NULL
415-858-3986	NULL
;	NULL
E-mail	NULL
:	NULL
hf.Imb	NULL
@	NULL
forsythe.stanford.edu	NULL
.	NULL

translocated	NULL
c-myc	NULL
gene	NULL
.	NULL

The	NULL
nm23	NULL
gene	NULL
products	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
tumor	NULL
metastasis	NULL
by	NULL
mechanisms	NULL
that	NULL
are	NULL
not	NULL
known	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
metastatic	NULL
potential	NULL
of	NULL
tumor	NULL
cells	NULL
has	NULL
been	NULL
correlated	NULL
with	NULL
reduced	NULL
nm23	NULL
expression	NULL
(	NULL
20-23	NULL
)	NULL
.	NULL

In	NULL
other	NULL
tumor	NULL
types	NULL
,	NULL
over-expression	NULL
of	NULL
nm23	NULL
correlates	NULL
with	NULL
metastatic	NULL
spread	NULL
(	NULL
24-28	NULL
)	NULL
.	NULL

The	NULL
nm23	NULL
gene	NULL
products	NULL
are	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
development	NULL
(	NULL
29-31	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
contain	NULL
nucleoside	NULL
diphosphate	NULL
kinase	NULL
enzyme	NULL
activity	NULL
(	NULL
32-35	NULL
)	NULL
.	NULL

Nm23	NULL
proteins	NULL
interact	NULL
with	NULL
GTP-binding	NULL
proteins	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
and	NULL
they	NULL
also	NULL
function	NULL
as	NULL
transcription	NULL
factors	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
,	NULL
PuF	NULL
,	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
Nm23H2	NULL
protein	NULL
(	NULL
37	NULL
)	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
at	NULL
-	NULL
142	NULL
to	NULL
-115	NULL
upstream	NULL
of	NULL
the	NULL
ec-mye	NULL
P1	NULL
promoter	NULL
(	NULL
the	NULL
PuF	NULL
site	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
e-mye	NULL
transcription	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
required	NULL
for	NULL
ir	NULL
vitro	NULL
transcription	NULL
from	NULL
both	NULL
promoters	NULL
P1	NULL
and	NULL
P2	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
nucleoside	NULL
diphosphate	NULL
kinase	NULL
enzyme	NULL
activity	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
in	NULL
vitro	NULL
transcriptional	NULL
activity	NULL
of	NULL
Nm23H2	NULL
(	NULL
40	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
demonstrated	NULL
that	NULL
the	NULL
PuF	NULL
site	NULL
on	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
is	NULL
bound	NULL
by	NULL
protein	NULL
in	NULL
vivo	NULL
while	NULL
the	NULL
PuF	NULL
site	NULL
on	NULL
the	NULL
silent	NULL
normal	NULL
e-myce	NULL
allele	NULL
is	NULL
not	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
demonstrate	NULL
that	NULL
the	NULL
PuF	NULL
site	NULL
functions	NULL
as	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Lines-DHL-9	NULL
is	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
transloca-tion	NULL
of	NULL
the	NULL
c-myc	NULL
gene	NULL
;	NULL
Raji	NULL
is	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
.	NULL

They	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Plasmid	NULL
Constructs-pMPCAT	NULL
(	NULL
41	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
c-myc	NULL
residues	NULL
-2328	NULL
to	NULL
+936	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
D.	NULL
Levens	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
)	NULL
.	NULL

Mutations	NULL
were	NULL
created	NULL
in	NULL
the	NULL
»	NULL
m23HH2	NULL
site	NULL
by	NULL
PCR	NULL
mutagen-esis	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
were	NULL
5'-site	NULL
(	NULL
MP1	NULL
)	NULL
,	NULL
CCTTCCACACGCTC-CCCACC	NULL
;	NULL
3'-site	NULL
(	NULL
MP2	NULL
)	NULL
,	NULL
CCTTCCCCACCCTCCGCACTCTC	NULL
;	NULL
double	NULL
mutant	NULL
(	NULL
MP3	NULL
)	NULL
,	NULL
CCTTCCACACGCTCCGCACTCTC	NULL
(	NULL
the	NULL
mutated	NULL
bases	NULL
are	NULL
underlined	NULL
)	NULL
.	NULL

Mutations	NULL
were	NULL
confirmed	NULL
by	NULL
sequencing	NULL
(	NULL
Sequenase	NULL
kit	NULL
,	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

In	NULL
Vivo	NULL
Dimethyl	NULL
Sulfate	NULL
(	NULL
DMS	NULL
)	NULL
Treatment	NULL
and	NULL
DNA	NULL
Isolation-DNA	NULL
isolation	NULL
after	NULL
DMS	NULL
treatment	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
19	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
Sacl	NULL
,	NULL
and	NULL
agarose	NULL
electrophoresis	NULL
was	NULL
performed	NULL
to	NULL
separate	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
from	NULL
the	NULL
normal	NULL
one	NULL
.	NULL

One	NULL
lane	NULL
of	NULL
the	NULL
gel	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
filter	NULL
;	NULL
probes	NULL
consisting	NULL
of	NULL
c-myc	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
and	NULL
the	NULL
immunoglobulin	NULL
L	NULL
heavy-chain	NULL
constant	NULL
region	NULL
were	NULL
used	NULL
sequentially	NULL
to	NULL
locate	NULL
the	NULL
two	NULL
c-myc	NULL
alleles	NULL
.	NULL

The	NULL
DNA	NULL
in	NULL
these	NULL
two	NULL
regions	NULL
was	NULL
electroeluted	NULL
from	NULL
the	NULL
gel	NULL
.	NULL

Cleavage	NULL
with	NULL
piperidine	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
Maxam-Gilbert	NULL
procedure	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Ligation-mediated	NULL
PCR-Chemically	NULL
modified	NULL
and	NULL
cleaved	NULL
DNA	NULL
was	NULL
then	NULL
subjected	NULL
to	NULL
amplification	NULL
by	NULL
ligation-mediated	NULL
PCR	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Mueller	NULL
and	NULL
Wold	NULL
(	NULL
46	NULL
)	NULL
,	NULL
Pfeifer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
Garrity	NULL
and	NULL
Wold	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Sequenase	NULL
was	NULL
used	NULL
for	NULL
first	NULL
strand	NULL
synthesis	NULL
,	NULL
and	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
was	NULL
used	NULL
for	NULL
PCR	NULL
.	NULL

Conditions	NULL
used	NULL
for	NULL
amplification	NULL
were	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
DMS	NULL
,	NULL
dimethyl	NULL
sulfate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pairs	NULL
.	NULL

13392	NULL
Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Translocated	NULL
e-mye	NULL
Allele	NULL
95	NULL
°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
61	NULL
°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
and	NULL
76	NULL
°C	NULL
for	NULL
3	NULL
min	NULL
.	NULL

After	NULL
20-22	NULL
cycles	NULL
of	NULL
PCR	NULL
,	NULL
samples	NULL
were	NULL
hybridized	NULL
with	NULL
end-labeled	NULL
primers	NULL
(	NULL
primer	NULL
3	NULL
of	NULL
each	NULL
primer	NULL
set	NULL
)	NULL
and	NULL
amplified	NULL
by	NULL
one	NULL
more	NULL
cycle	NULL
of	NULL
PCR	NULL
.	NULL

The	NULL
reaction	NULL
mixes	NULL
were	NULL
resolved	NULL
in	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
denaturing	NULL
gel	NULL
.	NULL

Footprinting	NULL
on	NULL
each	NULL
strand	NULL
was	NULL
repeated	NULL
at	NULL
least	NULL
four	NULL
times	NULL
with	NULL
genomic	NULL
DNA	NULL
samples	NULL
prepared	NULL
from	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
batches	NULL
of	NULL
DMS-treated	NULL
cells	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
for	NULL
PCR	NULL
were	NULL
synthesized	NULL
in	NULL
an	NULL
Applied	NULL
Biosystems	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
and	NULL
purified	NULL
on	NULL
Applied	NULL
Biosystems	NULL
oligonucleotide	NULL
purification	NULL
cartridges	NULL
.	NULL

The	NULL
common	NULL
linkers	NULL
used	NULL
were	NULL
GCGGTGACCCGGGAGATCTGAATTC	NULL
and	NULL
GAATTCAGATC	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
the	NULL
coding	NULL
strand	NULL
were	NULL
GACCCTCGCATTATAAAGGG-CCG	NULL
,	NULL
AAAGGGCCGGTGGGCGGAGATTAG	NULL
,	NULL
and	NULL
AAAGGGCCGGT-GGGCGGAGATTAGCG	NULL
.	NULL

The	NULL
noncoding	NULL
strand	NULL
primers	NULL
were	NULL
GGAGA-GGGTTTGAGAGGGAGC	NULL
,	NULL
GGCGCGCGTAGTTAATTCATGCGGC	NULL
,	NULL
and	NULL
GGCGCGCGTAGTTAATTCATGCGGCTCTC	NULL
.	NULL

Quantitation	NULL
of	NULL
footprints	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
43	NULL
)	NULL
with	NULL
ImageQuant	NULL
software	NULL
version	NULL
4.15	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Percent	NULL
protection	NULL
values	NULL
of	NULL
below	NULL
20	NULL
%	NULL
were	NULL
considered	NULL
too	NULL
low	NULL
and	NULL
were	NULL
not	NULL
interpreted	NULL
as	NULL
footprints	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-The	NULL
double-stranded	NULL
oligonucleotides	NULL
used	NULL
for	NULL
EMSA	NULL
are	NULL
shown	NULL
below	NULL
.	NULL

Mutated	NULL
bases	NULL
are	NULL
underlined	NULL
.	NULL

CCTTCCCCACCCTCCCCACCCTCC	NULL
GGAAGGGGTGGGAGGGGTGGGAGG	NULL
OLIGONUCLEOTIDE	NULL
PuF	NULL
CCTTCCACACGCTCCCCACCCTCC	NULL
GGAAGGTGTGCGAGGGGTGGGACGG	NULL
MP1	NULL
CCTTCCCCACCCTCCGCACTCTCC	NULL
GGAAGGGGTGGGAGGCGTGAGAGG	NULL
Ourconucirotipe	NULL
MP2	NULL
CCTTCCACACGCTCCGCACTCTCG	NULL
GGAAGGTGTGCGAGGCGTGAGAGC	NULL
OruiconuciEotipe	NULL
MP3	NULL
AATTAACTGCTTAACTGTCAA	NULL
TTAATTGACGAATTGACAGTT	NULL
OurconucLrotinE	NULL
Myb	NULL
The	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
with	NULL
5	NULL
'	NULL
overhangs	NULL
and	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
a-*	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
and	NULL
Klenow	NULL
.	NULL

The	NULL
F50	NULL
probe	NULL
of	NULL
the	NULL
c-myc	NULL
-flanking	NULL
region	NULL
extended	NULL
from	NULL
-148	NULL
to	NULL
-98	NULL
relative	NULL
to	NULL
promoter	NULL
PI	NULL
.	NULL

Binding	NULL
conditions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
12	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
4	NULL
mit	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mi	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mi	NULL
dithiothreitol	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
BSA	NULL
,	NULL
0.5	NULL
ng	NULL
(	NULL
10*	NULL
cpm	NULL
)	NULL
of	NULL
end-labeled	NULL
DNA	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
and	NULL
15-20	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
crude	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
conducted	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
0.5	NULL
x	NULL
Tris	NULL
borate-EDTA	NULL
,	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Electrophoresis	NULL
was	NULL
performed	NULL
at	NULL
30	NULL
mA	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

For	NULL
the	NULL
competition	NULL
studies	NULL
the	NULL
indicated	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

As	NULL
a	NULL
nonspecific	NULL
competitor	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Myb	NULL
binding	NULL
site	NULL
was	NULL
used	NULL
.	NULL

For	NULL
the	NULL
supershifts	NULL
,	NULL
the	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
as	NULL
above	NULL
with	NULL
incubation	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Antibody	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
Nm23H1/	NULL
Nm23H2	NULL
antibody	NULL
recognizes	NULL
a	NULL
region	NULL
in	NULL
the	NULL
homologous	NULL
C-terminals	NULL
of	NULL
human	NULL
Nm23H1	NULL
and	NULL
Nm23H2	NULL
.	NULL

The	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
Nm23H1/Nm23H2	NULL
and	NULL
Ets-1	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Bio-technology	NULL
.	NULL

UV	NULL
Cross-linking	NULL
and	NULL
SDS-Polyacrylamide	NULL
Gel	NULL
Electrophoresis-EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
wet	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
film	NULL
to	NULL
locate	NULL
the	NULL
EMSA	NULL
complexes	NULL
.	NULL

UV	NULL
cross-linking	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
49	NULL
)	NULL
with	NULL
a	NULL
short	NULL
wavelength	NULL
UV	NULL
light	NULL
box	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Regions	NULL
of	NULL
the	NULL
gel	NULL
containing	NULL
the	NULL
complexes	NULL
were	NULL
cut	NULL
out	NULL
,	NULL
and	NULL
the	NULL
individual	NULL
complexes	NULL
were	NULL
eluted	NULL
at	NULL
room	NULL
temperature	NULL
overnight	NULL
in	NULL
50	NULL
mi	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
my	NULL
EDTA	NULL
,	NULL
5	NULL
mit	NULL
dithiothreitol	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
0.1	NULL
mg/ml	NULL
BSA	NULL
.	NULL

The	NULL
eluted	NULL
protein	NULL
was	NULL
precipitated	NULL
with	NULL
4	NULL
volumes	NULL
of	NULL
acetone	NULL
,	NULL
washed	NULL
with	NULL
ethanol	NULL
,	NULL
and	NULL
air	NULL
dried	NULL
.	NULL

After	NULL
resuspension	NULL
in	NULL
Laemmli	NULL
loading	NULL
buffer	NULL
,	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
Amersham	NULL
ECL	NULL
kit	NULL
was	NULL
used	NULL
for	NULL
Western	NULL
analysis	NULL
.	NULL

In	NULL
Vitro	NULL
Methylation	NULL
Interference-3'-End-labeled	NULL
DNA	NULL
fragment	NULL
(	NULL
labeled	NULL
with	NULL
Klenow	NULL
polymerase	NULL
at	NULL
HindIII	NULL
site	NULL
on	NULL
the	NULL
antisense	NULL
strand	NULL
)	NULL
or	NULL
5'-end-labeled	NULL
oligonucleotide	NULL
(	NULL
labeled	NULL
with	NULL
T4	NULL
kinase	NULL
on	NULL
the	NULL
anti	NULL
13393	NULL
Coding	NULL
Noncoding	NULL
8	NULL
N	NULL
v	NULL
T	NULL
v	NULL
G	NULL
-112	NULL
G	NULL
A	NULL
Ge	NULL
Ge	NULL
G	NULL
'	NULL
®	NULL
p1	NULL
Go	NULL
G*	NULL
»	NULL
Ge	NULL
-III-1	NULL
Ge	NULL
A	NULL
Go	NULL
Ge	NULL
Ge	NULL
T	NULL
G*	NULL
Ge	NULL
-95	NULL
-184	NULL
Ge	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
analysis	NULL
by	NULL
ligation-mediated	NULL
PCR	NULL
of	NULL
the	NULL
c-mye	NULL
DNase	NULL
hypersensitive	NULL
site	NULL
III-1	NULL
in	NULL
Raji	NULL
cells	NULL
.	NULL

The	NULL
region	NULL
illustrated	NULL
is	NULL
labeled	NULL
by	NULL
nucleotide	NULL
number	NULL
relative	NULL
to	NULL
the	NULL
e-myc	NULL
P1	NULL
promoter	NULL
.	NULL

V	NULL
denotes	NULL
in	NULL
vitro	NULL
methylated	NULL
DNA	NULL
(	NULL
lane	NULL
2	NULL
is	NULL
from	NULL
the	NULL
normal	NULL
c-myc	NULL
allele	NULL
,	NULL
and	NULL
lane	NULL
4	NULL
is	NULL
from	NULL
the	NULL
translocated	NULL
allele	NULL
)	NULL
,	NULL
T	NULL
denotes	NULL
in	NULL
vivo	NULL
methylated	NULL
DNA	NULL
from	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
,	NULL
and	NULL
N	NULL
denotes	NULL
in	NULL
vivo	NULL
methylated	NULL
DNA	NULL
from	NULL
the	NULL
normal	NULL
e-mye	NULL
allele	NULL
.	NULL

The	NULL
protected	NULL
guanines	NULL
are	NULL
marked	NULL
by	NULL
closed	NULL
circles	NULL
.	NULL

Protection	NULL
of	NULL
guanine	NULL
is	NULL
56	NULL
%	NULL
at	NULL
positions	NULL
-117	NULL
,	NULL
-118	NULL
,	NULL
and	NULL
-119	NULL
;	NULL
82	NULL
%	NULL
at	NULL
-121	NULL
,	NULL
-122	NULL
,	NULL
-123	NULL
,	NULL
and	NULL
-124	NULL
;	NULL
71	NULL
%	NULL
at	NULL
-126	NULL
,	NULL
-127	NULL
,	NULL
and	NULL
-128	NULL
;	NULL
and	NULL
65	NULL
%	NULL
at	NULL
-130	NULL
,	NULL
-131	NULL
,	NULL
and	NULL
-132.	NULL
sense	NULL
strand	NULL
)	NULL
was	NULL
methylated	NULL
with	NULL
0.5	NULL
%	NULL
DMS	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

This	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
EMSA	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
wet	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
locate	NULL
the	NULL
complexes	NULL
,	NULL
and	NULL
both	NULL
the	NULL
bound	NULL
and	NULL
free	NULL
probe	NULL
were	NULL
excised	NULL
and	NULL
transferred	NULL
to	NULL
DEAE	NULL
membranes	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
eluted	NULL
and	NULL
cleaved	NULL
with	NULL
piperidine	NULL
,	NULL
and	NULL
equal	NULL
counts	NULL
of	NULL
bound	NULL
and	NULL
free	NULL
samples	NULL
were	NULL
resolved	NULL
in	NULL
a	NULL
15	NULL
%	NULL
acrylamide	NULL
sequencing	NULL
gel	NULL
.	NULL

Transfections	NULL
and	NULL
Chloramphenicol	NULL
Acetyltransferase	NULL
Assays-Transfections	NULL
were	NULL
performed	NULL
on	NULL
cells	NULL
in	NULL
log	NULL
phase	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
unsupplemented	NULL
RPMI	NULL
medium	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
and	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
after	NULL
addition	NULL
of	NULL
15	NULL
ug	NULL
of	NULL
DNA	NULL
plus	NULL
10	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Electroporations	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
at	NULL
350	NULL
mV	NULL
,	NULL
960	NULL
microfarads	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
again	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
23	NULL
ml	NULL
of	NULL
supplemented	NULL
RPMI	NULL
for	NULL
48	NULL
h.	NULL
Chloramphenicol	NULL
acetyltransferase	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
standard	NULL
manner	NULL
(	NULL
51	NULL
)	NULL
with	NULL
a	NULL
2-h	NULL
enzyme	NULL
assay	NULL
.	NULL

Percent	NULL
acetylation	NULL
was	NULL
quantified	NULL
with	NULL
a	NULL
Molecular	NULL
Devices	NULL
phospho-rimager	NULL
.	NULL

Variation	NULL
in	NULL
transfection	NULL
efficiency	NULL
was	NULL
controlled	NULL
for	NULL
by	NULL
co-transfection	NULL
with	NULL
Rous	NULL
sarcoma	NULL
virus-B-galactosidase	NULL
.	NULL

Each	NULL
assay	NULL
was	NULL
performed	NULL
at	NULL
least	NULL
three	NULL
times	NULL
in	NULL
duplicate	NULL
with	NULL
at	NULL
least	NULL
two	NULL
different	NULL
plasmid	NULL
preps	NULL
.	NULL

The	NULL
average	NULL
value	NULL
with	NULL
the	NULL
standard	NULL
deviation	NULL
is	NULL
plotted	NULL
.	NULL

RESULTS	NULL
An	NULL
in	NULL
Vivo	NULL
Footprint	NULL
Is	NULL
Located	NULL
Near	NULL
DNase	NULL
Hypersensitive	NULL
Site	NULL
III-1-The	NULL
translocated	NULL
and	NULL
normal	NULL
c-myc	NULL
alleles	NULL
from	NULL
Raji	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
,	NULL
and	NULL
ligation-mediated	NULL
PCR	NULL
was	NULL
performed	NULL
on	NULL
each	NULL
one	NULL
.	NULL

With	NULL
primer	NULL
sets	NULL
that	NULL
cover	NULL
the	NULL
region	NULL
surrounding	NULL
DNase	NULL
hypersensitive	NULL
site	NULL
III-1	NULL
,	NULL
we	NULL
found	NULL
a	NULL
footprint	NULL
on	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
that	NULL
was	NULL
not	NULL
present	NULL
on	NULL
the	NULL
normal	NULL
silent	NULL
c-myc	NULL
allele	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

There	NULL
were	NULL
13	NULL
guanine	NULL
residues	NULL
protected	NULL
on	NULL
the	NULL
noncoding	NULL
strand	NULL
.	NULL

There	NULL
are	NULL
no	NULL
guanine	NULL
residues	NULL
in	NULL
this	NULL
region	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
.	NULL

The	NULL
protected	NULL
sequence	NULL
contains	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
Nm23H2	NULL
,	NULL
Sp-1	NULL
,	NULL
and	NULL
AP-2	NULL
.	NULL

Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Protected	NULL
Sequence	NULL
in	NULL
Vitro-To	NULL
determine	NULL
which	NULL
proteins	NULL
in	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
bound	NULL
to	NULL
the	NULL
protected	NULL
sequence	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
.	NULL

A	NULL
50-bp	NULL
fragment	NULL
(	NULL
F50	NULL
probe	NULL
)	NULL
encompassing	NULL
this	NULL
region	NULL
of	NULL
the	NULL
e-mye	NULL
promoter	NULL
and	NULL
a	NULL
24-bp	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
PuF	NULL
probe	NULL
)	NULL
were	NULL
both	NULL
labeled	NULL
and	NULL
used	NULL
as	NULL
probes	NULL
in	NULL
EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
both	NULL
DHL-9	NULL
and	NULL
Raji	NULL
B	NULL
cell	NULL
lines	NULL
to	NULL
deter	NULL
13394	NULL
Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Translocated	NULL
e-mye	NULL
Allele	NULL
A	NULL
B	NULL
F50	NULL
Probe	NULL
PUF	NULL
Probe	NULL
o	NULL
so	NULL
100	NULL
100	NULL
100	NULL
0	NULL
_	NULL
50	NULL
100	NULL
100	NULL
100	NULL
0	NULL
so	NULL
100	NULL
100	NULL
100	NULL
0	NULL
50	NULL
100	NULL
100	NULL
100	NULL
F50	NULL
F50	NULL
F50	NULL
Myb	NULL
PUF	NULL
F50	NULL
F50	NULL
F50	NULL
Myb	NULL
PUF	NULL
FUF	NULL
PUF	NULL
PUF	NULL
F50	NULL
Myb	NULL
PUF	NULL
PUF	NULL
PUF	NULL
F50	NULL
Myb	NULL
W	NULL
With	NULL
-	NULL
wth	NULL
<	NULL
<	NULL
:	NULL
<	NULL
4-	NULL
C3	NULL
<	NULL
4-	NULL
C4	NULL
f	NULL
bs	NULL
ve	NULL
$	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
70	NULL
8	NULL
9	NULL
10	NULL
1°	NULL
2	NULL
%	NULL
3	NULL
4	NULL
5	NULL
7	NULL
8	NULL
9	NULL
10	NULL
<	NULL
-	NULL
ie	NULL
>	NULL
<	NULL
4	NULL
--	NULL
--	NULL
--	NULL
-p	NULL
4—D	NULL
DHL-9	NULL
Raji	NULL
DHL-9	NULL
Raji	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

EMSA	NULL
of	NULL
the	NULL
PuF	NULL
binding	NULL
site	NULL
DNA	NULL
fragment	NULL
and	NULL
oligonucleotide	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
with	NULL
the	NULL
50-bp	NULL
DNA	NULL
fragment	NULL
(	NULL
F50	NULL
)	NULL
as	NULL
probe	NULL
.	NULL

Cold	NULL
PuF	NULL
DNA	NULL
fragment	NULL
(	NULL
F50	NULL
)	NULL
,	NULL
PuF	NULL
site	NULL
oligonucleotide	NULL
(	NULL
PUF	NULL
)	NULL
,	NULL
and	NULL
a	NULL
c-Myb	NULL
consensus	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
(	NULL
Myb	NULL
)	NULL
at	NULL
the	NULL
indicated	NULL
molar	NULL
excess	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
.	NULL

Lanes	NULL
1-5	NULL
,	NULL
EMSA	NULL
with	NULL
DHL-9	NULL
nuclear	NULL
extract	NULL
;	NULL
lanes	NULL
6-10	NULL
,	NULL
EMSA	NULL
with	NULL
Raji	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
predominant	NULL
EMSA	NULL
complex	NULL
is	NULL
labeled	NULL
C7	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
with	NULL
the	NULL
24-bp	NULL
PuF	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
(	NULL
PUF	NULL
)	NULL
as	NULL
probe	NULL
.	NULL

The	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
cold	NULL
PuF	NULL
oligonucleotide	NULL
,	NULL
F50	NULL
DNA	NULL
fragment	NULL
,	NULL
or	NULL
Myb	NULL
competitor	NULL
in	NULL
each	NULL
lane	NULL
is	NULL
indicated	NULL
.	NULL

EMSA	NULL
complexes	NULL
are	NULL
labeled	NULL
C2-C4	NULL
,	NULL
respectively	NULL
.	NULL

DHL-9	NULL
Raji	NULL
#	NULL
+	NULL
+	NULL
+	NULL
*	NULL
+	NULL
+	NULL
+	NULL
PL	NULL
PI	NULL
PUF	NULL
ETS	NULL
PI	NULL
PI	NULL
PUF	NULL
ETS	NULL
``	NULL
W	NULL
<	NULL
-	NULL
c2	NULL
-o	NULL
40	NULL
40	NULL
4	NULL
00	NULL
>	NULL
4+	NULL
#	NULL
0	NULL
0+	NULL
PI	NULL
PI	NULL
PUF	NULL
ETS1	NULL
PLI	NULL
PI	NULL
PUF	NULL
ETS	NULL
WH	NULL
_	NULL
W	NULL
<	NULL
-	NULL
cz	NULL
ci-	NULL
»	NULL
Wo	NULL
bw	NULL
_	NULL
bu	NULL
C1*	NULL
>	NULL
WW	NULL
b	NULL
_	NULL
be	NULL
<	NULL
4-	NULL
C3	NULL
<	NULL
4-	NULL
C3	NULL
<	NULL
4-	NULL
C4	NULL
4-	NULL
C4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
8	NULL
1	NULL
2	NULL
%	NULL
3	NULL
4	NULL
5	NULL
60	NULL
170	NULL
8	NULL
<	NULL
4	NULL
--	NULL
-Pp	NULL
_-	NULL
4	NULL
--	NULL
-Pp	NULL
<	NULL
4	NULL
--	NULL
--	NULL
Jp	NULL
-	NULL
4	NULL
--	NULL
-p	NULL
F50	NULL
Probe	NULL
PUF	NULL
Probe	NULL
F50	NULL
Probe	NULL
PUF	NULL
Probe	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
antibodies	NULL
on	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
PuF	NULL
binding	NULL
site	NULL
DNA	NULL
fragment	NULL
or	NULL
oligonucleotide	NULL
.	NULL

A	NULL
,	NULL
effect	NULL
of	NULL
antibodies	NULL
on	NULL
the	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
DHL-9	NULL
nuclear	NULL
extract	NULL
and	NULL
PuF	NULL
DNA	NULL
fragment	NULL
(	NULL
F50	NULL
)	NULL
(	NULL
lanes	NULL
1-4	NULL
)	NULL
or	NULL
oligonucleotide	NULL
(	NULL
PUF	NULL
)	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

Lanes	NULL
1-5	NULL
,	NULL
without	NULL
preimmune	NULL
serum	NULL
(	NULL
-P	NULL
)	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
with	NULL
preimmune	NULL
serum	NULL
(	NULL
+P17	NULL
)	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
with	NULL
anti-PuF	NULL
(	NULL
Nm23H1/Nm23H2	NULL
)	NULL
antibody	NULL
(	NULL
+PUF	NULL
)	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
with	NULL
anti-Ets-1	NULL
antibody	NULL
(	NULL
+ETS1	NULL
)	NULL
.	NULL

The	NULL
EMSA	NULL
complexes	NULL
C1-C4	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

B	NULL
,	NULL
effect	NULL
of	NULL
antibodies	NULL
on	NULL
the	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
Raji	NULL
nuclear	NULL
extract	NULL
and	NULL
PuF	NULL
DNA	NULL
fragment	NULL
or	NULL
oligonucleotide	NULL
.	NULL

The	NULL
lanes	NULL
and	NULL
complexes	NULL
are	NULL
labeled	NULL
as	NULL
described	NULL
above	NULL
for	NULL
panel	NULL
A.	NULL
Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Translocated	NULL
e-mye	NULL
Allele	NULL
KD	NULL
C1	NULL
C2	NULL
C3	NULL
C4	NULL
C1	NULL
C2	NULL
C3	NULL
C4	NULL
w-se	NULL
foud	NULL
.	NULL

mse	NULL
-	NULL
.	NULL

Wit	NULL
-	NULL
wage	NULL
200.0	NULL
-	NULL
@	NULL
&	NULL
wae	NULL
trs	NULL
was	NULL
#	NULL
p	NULL
--	NULL
-	NULL
was	NULL
97.4	NULL
69.0	NULL
--	NULL
46.0	NULL
is	NULL
36.0	NULL
-	NULL
”	NULL
-	NULL
21.5	NULL
-	NULL
-	NULL
.	NULL

14.3	NULL
«	NULL
me	NULL
<	NULL
-	NULL
38	NULL
KD	NULL
dtr	NULL
«	NULL
<	NULL
&	NULL
-	NULL
17	NULL
KD	NULL
200.0	NULL
97.4	NULL
69.0	NULL
46.0	NULL
«	NULL
G-	NULL
38	NULL
KD	NULL
36.0	NULL
=-	NULL
21.5	NULL
14.3	NULL
200.0	NULL
97.4	NULL
69.0	NULL
46.0	NULL
36.0	NULL
21.5	NULL
DHL-9	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
e-mye	NULL
PuF	NULL
site	NULL
.	NULL

A	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
UV	NULL
cross-linked	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
c-myc	NULL
PuF	NULL
site	NULL
using	NULL
anti-PuF	NULL
(	NULL
Nm23H1/Nm23H2	NULL
)	NULL
polyclonal	NULL
antibody	NULL
.	NULL

Lanes	NULL
that	NULL
contain	NULL
proteins	NULL
from	NULL
the	NULL
corresponding	NULL
EMSA	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
are	NULL
labeled	NULL
as	NULL
CI-C4	NULL
,	NULL
respectively	NULL
.	NULL

Lanes	NULL
1-4	NULL
,	NULL
proteins	NULL
from	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
DHL-9	NULL
nuclear	NULL
extract	NULL
and	NULL
PuF	NULL
DNA	NULL
fragment	NULL
(	NULL
C1	NULL
)	NULL
or	NULL
oligonucleotide	NULL
(	NULL
C2-C4	NULL
)	NULL
;	NULL
lanes	NULL
5-8	NULL
,	NULL
proteins	NULL
from	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
Raji	NULL
nuclear	NULL
extract	NULL
and	NULL
PuF	NULL
DNA	NULL
(	NULL
C1	NULL
)	NULL
or	NULL
oligonucleotide	NULL
(	NULL
C2-C4	NULL
)	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
molecular	NULL
mass	NULL
markers	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
protein	NULL
bands	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
38	NULL
and	NULL
17	NULL
kDa	NULL
are	NULL
identified	NULL
as	NULL
the	NULL
UV	NULL
cross-linked	NULL
complex	NULL
formed	NULL
with	NULL
Nm23H2	NULL
protein	NULL
and	NULL
DNA	NULL
probe	NULL
and	NULL
the	NULL
unbound	NULL
Nm23H2	NULL
protein	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
68-kDa	NULL
band	NULL
is	NULL
BSA	NULL
,	NULL
which	NULL
is	NULL
added	NULL
to	NULL
the	NULL
elution	NULL
buffer	NULL
.	NULL

There	NULL
is	NULL
some	NULL
cross-reactivity	NULL
of	NULL
the	NULL
antibody	NULL
with	NULL
BSA	NULL
.	NULL

B	NULL
,	NULL
denaturing	NULL
SDS-polyacrylamide	NULL
gel	NULL
analysis	NULL
of	NULL
the	NULL
UV	NULL
cross-linked	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
c-myc	NULL
PuF	NULL
site	NULL
.	NULL

The	NULL
image	NULL
was	NULL
generated	NULL
from	NULL
the	NULL
autoradiography	NULL
of	NULL
*°P-labeled	NULL
bands	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
lanes	NULL
are	NULL
labeled	NULL
as	NULL
described	NULL
above	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
UV	NULL
cross-linked	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
Nm23H2	NULL
and	NULL
the	NULL
c-myc	NULL
PuF	NULL
site	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
;	NULL
these	NULL
complexes	NULL
comigrate	NULL
with	NULL
the	NULL
38-kDa	NULL
bands	NULL
on	NULL
the	NULL
Western	NULL
blot	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

C	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
noncross-linked	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
c-myc	NULL
PuF	NULL
site	NULL
,	NULL
using	NULL
anti-PuF	NULL
(	NULL
Nm23H1/	NULL
Nm23H2	NULL
)	NULL
polyclonal	NULL
antibody	NULL
.	NULL

The	NULL
lanes	NULL
are	NULL
labeled	NULL
as	NULL
described	NULL
above	NULL
for	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
unbound	NULL
Nm23H2	NULL
protein	NULL
shows	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
17	NULL
kDa	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

mine	NULL
whether	NULL
there	NULL
were	NULL
any	NULL
differences	NULL
in	NULL
the	NULL
proteins	NULL
present	NULL
in	NULL
Burkitt	NULL
's	NULL
cells	NULL
versus	NULL
a	NULL
B	NULL
cell	NULL
line	NULL
lacking	NULL
a	NULL
translo-cation	NULL
of	NULL
the	NULL
e-mye	NULL
gene	NULL
.	NULL

One	NULL
major	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
13395	NULL
both	NULL
DHL-9	NULL
and	NULL
Raji	NULL
nuclear	NULL
extract	NULL
and	NULL
the	NULL
F50	NULL
probe	NULL
(	NULL
CT	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Three	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
both	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
oligonucleotide	NULL
(	NULL
C2	NULL
,	NULL
C3	NULL
,	NULL
and	NULL
C4	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
cold	NULL
self-competitor	NULL
diminished	NULL
the	NULL
intensity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
complexes	NULL
,	NULL
while	NULL
an	NULL
irrelevant	NULL
oligonucleotide	NULL
,	NULL
which	NULL
contained	NULL
the	NULL
Myb	NULL
binding	NULL
site	NULL
,	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
C1	NULL
and	NULL
C2	NULL
,	NULL
but	NULL
it	NULL
did	NULL
compete	NULL
for	NULL
formation	NULL
of	NULL
complexes	NULL
C3	NULL
and	NULL
C4	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
the	NULL
C3	NULL
and	NULL
C4	NULL
complexes	NULL
are	NULL
nonspecific	NULL
interactions	NULL
.	NULL

The	NULL
PuF	NULL
probe	NULL
competed	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
C1	NULL
seen	NULL
with	NULL
the	NULL
F50	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
F50	NULL
probe	NULL
competed	NULL
for	NULL
formation	NULL
of	NULL
complex	NULL
C2	NULL
formed	NULL
with	NULL
the	NULL
PuF	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
same	NULL
protein	NULL
or	NULL
proteins	NULL
were	NULL
most	NULL
likely	NULL
present	NULL
in	NULL
the	NULL
C1	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
F50	NULL
fragment	NULL
and	NULL
the	NULL
C2	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
PuF	NULL
probe	NULL
.	NULL

The	NULL
F50	NULL
and	NULL
PuF	NULL
probes	NULL
contain	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
transcription	NULL
factors	NULL
,	NULL
so	NULL
further	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
identify	NULL
the	NULL
relevant	NULL
proteins	NULL
.	NULL

An	NULL
antibody	NULL
that	NULL
is	NULL
reactive	NULL
with	NULL
both	NULL
Nm23H1	NULL
and	NULL
Nm23H2	NULL
was	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
to	NULL
determine	NULL
whether	NULL
Nm23H2	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
complexes	NULL
C1-C4	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
preimmune	NULL
serum	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
either	NULL
complex	NULL
,	NULL
while	NULL
the	NULL
antibody	NULL
against	NULL
Nm23H1/Nm23H2	NULL
disrupted	NULL
both	NULL
complexes	NULL
C1	NULL
and	NULL
C2	NULL
.	NULL

No	NULL
supershifted	NULL
complex	NULL
was	NULL
visible	NULL
,	NULL
so	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
antibody	NULL
interfered	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
Nm23H2	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

There	NULL
was	NULL
no	NULL
consistent	NULL
effect	NULL
on	NULL
complexes	NULL
C3	NULL
and	NULL
C4	NULL
,	NULL
and	NULL
there	NULL
was	NULL
no	NULL
effect	NULL
with	NULL
an	NULL
irrelevant	NULL
antibody	NULL
against	NULL
Ets-1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
Nm23H2	NULL
bound	NULL
to	NULL
the	NULL
F50	NULL
and	NULL
PuF	NULL
probes	NULL
,	NULL
UV	NULL
cross-linking	NULL
and	NULL
Western	NULL
analysis	NULL
were	NULL
performed	NULL
.	NULL

UV	NULL
cross-linking	NULL
followed	NULL
by	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
was	NULL
performed	NULL
first	NULL
.	NULL

A	NULL
protein	NULL
of	NULL
molecular	NULL
mass	NULL
38	NULL
kDa	NULL
was	NULL
observed	NULL
with	NULL
both	NULL
the	NULL
complex	NULL
C1	NULL
with	NULL
the	NULL
50-bp	NULL
F50	NULL
fragment	NULL
and	NULL
the	NULL
complex	NULL
C2	NULL
with	NULL
the	NULL
PuF	NULL
oligonucleotide	NULL
of	NULL
the	NULL
protected	NULL
region	NULL
(	NULL
38	NULL
kDa	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
38-kDa	NULL
protein	NULL
reacted	NULL
with	NULL
the	NULL
Nm23H1/Nm23H2	NULL
antibody	NULL
on	NULL
Western	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
protein	NULL
which	NULL
was	NULL
present	NULL
in	NULL
the	NULL
EMSA	NULL
complex	NULL
and	NULL
was	NULL
not	NULL
UV	NULL
cross-linked	NULL
to	NULL
DNA	NULL
was	NULL
also	NULL
observed	NULL
(	NULL
17	NULL
kDa	NULL
band	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
correspond	NULL
to	NULL
the	NULL
size	NULL
of	NULL
Nm23H2	NULL
,	NULL
either	NULL
cross-linked	NULL
to	NULL
DNA	NULL
(	NULL
38	NULL
kDa	NULL
)	NULL
or	NULL
free	NULL
(	NULL
17	NULL
kDa	NULL
)	NULL
.	NULL

The	NULL
Western	NULL
analysis	NULL
performed	NULL
without	NULL
UV	NULL
cross-linking	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
DNA	NULL
demonstrated	NULL
that	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
complexes	NULL
C1	NULL
and	NULL
C2	NULL
was	NULL
17	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
both	NULL
Western	NULL
analyses	NULL
,	NULL
proteins	NULL
of	NULL
higher	NULL
molecular	NULL
mass	NULL
reacted	NULL
with	NULL
the	NULL
Nm23H1/Nm23H2	NULL
antibody	NULL
(	NULL
The	NULL
68-kDa	NULL
protein	NULL
is	NULL
BSA	NULL
,	NULL
which	NULL
is	NULL
added	NULL
to	NULL
the	NULL
elution	NULL
buffer	NULL
;	NULL
there	NULL
is	NULL
some	NULL
cross-reactivity	NULL
of	NULL
the	NULL
antibody	NULL
with	NULL
BSA	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
the	NULL
other	NULL
proteins	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
and	NULL
proteins	NULL
of	NULL
this	NULL
size	NULL
are	NULL
not	NULL
observed	NULL
cross-linked	NULL
to	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Nm23H2	NULL
is	NULL
present	NULL
in	NULL
complexes	NULL
C1	NULL
and	NULL
C2	NULL
and	NULL
that	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
for	NULL
Nm23H2	NULL
in	NULL
either	NULL
the	NULL
C3	NULL
or	NULL
C4	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A-C	NULL
)	NULL
.	NULL

Protection	NULL
of	NULL
the	NULL
PuF	NULL
Binding	NULL
Site	NULL
Is	NULL
Seen	NULL
in	NULL
Vitro-In	NULL
vitro	NULL
methylation	NULL
interference	NULL
was	NULL
performed	NULL
to	NULL
locate	NULL
the	NULL
guanine	NULL
residues	NULL
required	NULL
for	NULL
protein	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

With	NULL
the	NULL
F50	NULL
probe	NULL
,	NULL
methylation	NULL
of	NULL
seven	NULL
guanine	NULL
residues	NULL
interfered	NULL
with	NULL
protein	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
complex	NULL
C2	NULL
formed	NULL
with	NULL
the	NULL
PuF	NULL
probe	NULL
,	NULL
methylation	NULL
of	NULL
essentially	NULL
all	NULL
of	NULL
the	NULL
guanine	NULL
residues	NULL
interfered	NULL
with	NULL
protein	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

This	NULL
is	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
pattern	NULL
observed	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
Nm23H2	NULL
Site	NULL
Is	NULL
Functional	NULL
in	NULL
B	NULL
Cells-The	NULL
e-mye	NULL
promoter	NULL
is	NULL
active	NULL
in	NULL
both	NULL
DHL-9	NULL
and	NULL
Raji	NULL
cells	NULL
.	NULL

We	NULL
had	NULL
shown	NULL
that	NULL
Nm23H2	NULL
bound	NULL
to	NULL
the	NULL
e-mye	NULL
PuF	NULL
site	NULL
,	NULL
and	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
Nm23H2	NULL
binding	NULL
site	NULL
had	NULL
any	NULL
functional	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Mutations	NULL
were	NULL
introduced	NULL
into	NULL
either	NULL
the	NULL
5'-	NULL
or	NULL
3'-half	NULL
of	NULL
the	NULL
PuF	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
13396	NULL
Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Translocated	NULL
e-mye	NULL
Allele	NULL
F50	NULL
Probe	NULL
PUF	NULL
Probe	NULL
C1	NULL
C1	NULL
C2	NULL
F	NULL
B	NULL
F	NULL
B	NULL
F	NULL
GF	NULL
B	NULL
F	NULL
F	NULL
B	NULL
F	NULL
-116	NULL
Sade	NULL
eBe	NULL
,	NULL
,	NULL
,	NULL
#	NULL
*	NULL
..	NULL
®~*	NULL
@	NULL
%	NULL
;	NULL
f	NULL
-116	NULL
/c	NULL
-~	NULL
a+	NULL
A	NULL
®	NULL
wm	NULL
G	NULL
t	NULL
C	NULL
T	NULL
o	NULL
G*	NULL
1	NULL
c.\	NULL
c	NULL
ki	NULL
tL	NULL
]	NULL
G+	NULL
a+	NULL
T	NULL
M	NULL
T	NULL
G	NULL
+	NULL
G	NULL
‘	NULL
z	NULL
I	NULL
1	NULL
G+	NULL
T	NULL
G	NULL
*	NULL
%	NULL
:	NULL
w	NULL
*	NULL
G*	NULL
G+	NULL
G	NULL
*	NULL
C*	NULL
I	NULL
*	NULL
\c	NULL
.	NULL

G	NULL
*	NULL
&	NULL
z	NULL
1	NULL
>	NULL
4	NULL
A	NULL
G+	NULL
»	NULL
A	NULL
*	NULL
%	NULL
«	NULL
w	NULL
®	NULL
G+	NULL
.	NULL

A04	NULL
G	NULL
3°	NULL
4	NULL
a	NULL
>	NULL
125	NULL
C	NULL
l	NULL
.	NULL

G	NULL
G+	NULL
$	NULL
**	NULL
+4	NULL
A**	NULL
bs	NULL
z	NULL
G	NULL
*	NULL
«	NULL
«	NULL
G*	NULL
%	NULL
%	NULL
%	NULL
G	NULL
G	NULL
a	NULL
a	NULL
t	NULL
:	NULL
bud	NULL
A+	NULL
+133	NULL
y	NULL
,	NULL
*	NULL
\G	NULL
‘	NULL
G	NULL
+	NULL
la	NULL
r	NULL
>	NULL
I	NULL
>	NULL
+	NULL
#	NULL
%	NULL
®	NULL
pt	NULL
#	NULL
am	NULL
*	NULL
*	NULL
mean	NULL
1	NULL
10	NULL
2	NULL
%	NULL
3	NULL
1	NULL
2	NULL
3	NULL
40	NULL
5	NULL
6	NULL
7	NULL
<	NULL
4-p	NULL
<	NULL
4	NULL
--	NULL
p	NULL
1-P	NULL
>	NULL
_	NULL
<	NULL
-p	NULL
DHL-9	NULL
Raji	NULL
DHL-9	NULL
Raji	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
with	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
e-mye	NULL
PuF	NULL
DNA	NULL
fragment	NULL
and	NULL
oligonucleotide	NULL
(	NULL
antisense	NULL
strands	NULL
)	NULL
.	NULL

A	NULL
,	NULL
methylation	NULL
interference	NULL
analysis	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
PuF	NULL
DNA	NULL
fragment	NULL
(	NULL
F50	NULL
)	NULL
and	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

CJ	NULL
corresponds	NULL
to	NULL
the	NULL
EMSA	NULL
complex	NULL
C1	NULL
;	NULL
F	NULL
,	NULL
free	NULL
probe	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
;	NULL
B	NULL
,	NULL
protein-bound	NULL
probe	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
and	NULL
position	NULL
in	NULL
the	NULL
c-myc	NULL
promoter	NULL
region	NULL
where	NULL
methylation	NULL
interference	NULL
occurred	NULL
are	NULL
indicated	NULL
.	NULL

Bases	NULL
that	NULL
show	NULL
strong	NULL
protection	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
asterisk	NULL
,	NULL
and	NULL
bases	NULL
that	NULL
show	NULL
weak	NULL
protection	NULL
are	NULL
indicated	NULL
by	NULL
+	NULL
.	NULL

B	NULL
,	NULL
methylation	NULL
interference	NULL
analysis	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
PuF	NULL
oligonucleotide	NULL
and	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

C2	NULL
corresponds	NULL
to	NULL
the	NULL
EMSA	NULL
complexes	NULL
C2	NULL
.	NULL

The	NULL
lanes	NULL
are	NULL
labeled	NULL
as	NULL
described	NULL
above	NULL
for	NULL
panel	NULL
A.	NULL
G	NULL
,	NULL
G-specific	NULL
cleavage	NULL
products	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

A	NULL
B	NULL
C	NULL
P1	NULL
-m	NULL
P2	NULL
m	NULL
120	NULL
m	NULL
120	NULL
2402	NULL
b	NULL
0	NULL
926	NULL
:	NULL
bp	NULL
lr	NULL
P	NULL
Exon	NULL
ro	NULL
m	NULL
DHL-9	NULL
ro	NULL
m	NULL
DHL-wT	NULL
[	NULL
I	NULL
CAT	NULL
O	NULL
RAJI	NULL
-	NULL
O	NULL
RAJI	NULL
w	NULL
100	NULL
{	NULL
w	NULL
100	NULL
Hind	NULL
III	NULL
Sac	NULL
I	NULL
5	NULL
,	NULL
2	NULL
3	NULL
-138	NULL
Coppecccoaccemrcceccaccereccca-111	NULL
E	NULL
80	NULL
E	NULL
$	NULL
9.7	NULL
coaaccccrteccacccorceecacccecr	NULL
O	NULL
z	NULL
)	NULL
cererece	NULL
cecerere	NULL
*	NULL
~	NULL
so	NULL
{	NULL
C	NULL
so-	NULL
#	NULL
#	NULL
MPUFL	NULL
MPUF2	NULL
z	NULL
z	NULL
W	NULL
-	NULL
401	NULL
WQ	NULL
407	NULL
936	NULL
o	NULL
o	NULL
-148	NULL
Exon	NULL
Z	NULL
sie	NULL
DMC1	NULL
Cat	NULL
§	NULL
201	NULL
t	NULL
201	NULL
0	NULL
Sac	NULL
I	NULL
``	NULL
C	NULL
E	NULL
936	NULL
PA	NULL
0	NULL
#	NULL
0	NULL
7	NULL
-9	NULL
8	NULL
Exon	NULL
wT	NULL
MP1	NULL
MP2	NULL
MP3	NULL
DMCI	NULL
DMC2	NULL
DMC	NULL
2	NULL
car	NULL
0	NULL
Sac	NULL
I	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
mutated	NULL
PuF	NULL
site	NULL
on	NULL
the	NULL
e-mye	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
diagram	NULL
of	NULL
e-mye	NULL
promoter-chloramphenicol	NULL
acetyltransferase	NULL
constructs	NULL
used	NULL
for	NULL
transfection	NULL
experiments	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
PuF	NULL
site	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
c-myc	NULL
promoter	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
residues	NULL
involved	NULL
in	NULL
Nm23H2	NULL
protein	NULL
binding	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
mutants	NULL
(	NULL
MPUF1	NULL
and	NULL
MPUF2	NULL
)	NULL
on	NULL
either	NULL
half	NULL
of	NULL
the	NULL
PuF	NULL
palindromic	NULL
binding	NULL
sequence	NULL
are	NULL
shown	NULL
,	NULL
and	NULL
the	NULL
mutated	NULL
nucleotides	NULL
are	NULL
indicated	NULL
by	NULL
asterisks	NULL
.	NULL

Two	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
e-mye	NULL
promoter	NULL
(	NULL
DMC1	NULL
and	NULL
DMC2	NULL
)	NULL
are	NULL
also	NULL
illustrated	NULL
.	NULL

B	NULL
,	NULL
transient	NULL
transfection	NULL
analysis	NULL
of	NULL
the	NULL
e-mye	NULL
promoter-chloramphenicol	NULL
acetyltransferase	NULL
mutant	NULL
constructs	NULL
.	NULL

WT	NULL
,	NULL
wild-type	NULL
c-myc	NULL
promoter	NULL
construct	NULL
;	NULL
MP1	NULL
,	NULL
mutant	NULL
construct	NULL
of	NULL
the	NULL
first	NULL
half	NULL
PuF	NULL
binding	NULL
sequence	NULL
(	NULL
MPUF1	NULL
)	NULL
;	NULL
MP2	NULL
,	NULL
mutant	NULL
construct	NULL
of	NULL
the	NULL
second	NULL
half	NULL
PuF	NULL
binding	NULL
sequence	NULL
(	NULL
MPUF2	NULL
)	NULL
;	NULL
MP3	NULL
,	NULL
the	NULL
double	NULL
mutant	NULL
construct	NULL
including	NULL
both	NULL
MP1	NULL
and	NULL
MP2	NULL
mutated	NULL
residues	NULL
.	NULL

The	NULL
standard	NULL
deviation	NULL
for	NULL
the	NULL
MP3	NULL
construct	NULL
in	NULL
DHL-9	NULL
cells	NULL
was	NULL
0.2	NULL
;	NULL
this	NULL
value	NULL
was	NULL
too	NULL
small	NULL
to	NULL
be	NULL
plotted	NULL
.	NULL

C	NULL
,	NULL
transient	NULL
transfection	NULL
analysis	NULL
of	NULL
the	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
e-myce	NULL
promoter-chloramphenicol	NULL
acetyltransferase	NULL
constructs	NULL
.	NULL

DMC	NULL
1	NULL
,	NULL
deletion	NULL
construct	NULL
at	NULL
-148	NULL
of	NULL
the	NULL
e-mye	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
PuF	NULL
binding	NULL
site	NULL
;	NULL
DMC2	NULL
,	NULL
deletion	NULL
construct	NULL
at	NULL
-98	NULL
of	NULL
the	NULL
e-mye	NULL
promoter	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
PuF	NULL
binding	NULL
site	NULL
.	NULL

the	NULL
5'-	NULL
or	NULL
3'-half	NULL
of	NULL
the	NULL
site	NULL
decreased	NULL
dramatically	NULL
the	NULL
binding	NULL
-	NULL
both	NULL
the	NULL
C1	NULL
and	NULL
C2	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

of	NULL
Nm23H2	NULL
protein	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

No	NULL
complex	NULL
C2	NULL
Mutation	NULL
of	NULL
the	NULL
5'-half	NULL
of	NULL
the	NULL
site	NULL
decreased	NULL
activity	NULL
of	NULL
the	NULL
was	NULL
formed	NULL
with	NULL
either	NULL
mutated	NULL
oligonucleotide	NULL
,	NULL
and	NULL
the	NULL
mu-	NULL
_	NULL
c-myc	NULL
promoter	NULL
by	NULL
approximately	NULL
55	NULL
%	NULL
in	NULL
both	NULL
DHL-9	NULL
and	NULL
Raji	NULL
tated	NULL
oligonucleotides	NULL
were	NULL
much	NULL
weaker	NULL
competitors	NULL
against	NULL
_	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
3'-half	NULL
of	NULL
the	NULL
site	NULL
decreased	NULL
the	NULL
Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Translocated	NULL
e-mye	NULL
Allele	NULL
A	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
mutated	NULL
e-mye	NULL
PuF	NULL
F50	NULL
Probe	NULL
sites	NULL
on	NULL
protein	NULL
binding	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
with	NULL
Raji	NULL
nuclear	NULL
extract	NULL
and	NULL
the	NULL
PuF	NULL
DNA	NULL
fragment	NULL
and	NULL
oligonucleotide	NULL
as	NULL
probes	NULL
and	NULL
the	NULL
mutated	NULL
oligonucleotides	NULL
as	NULL
competitors	NULL
(	NULL
100-fold	NULL
molar	NULL
ex-cess	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
and	NULL
competitors	NULL
used	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
.	NULL

0	NULL
,	NULL
without	NULL
competitor	NULL
;	NULL
F50	NULL
,	NULL
50-bp	NULL
PuF	NULL
site	NULL
DNA	NULL
fragment	NULL
;	NULL
PUF	NULL
,	NULL
PuF	NULL
oligonucleotide	NULL
;	NULL
MP1	NULL
,	NULL
first	NULL
mutant	NULL
oligonucleotide	NULL
of	NULL
the	NULL
PuF	NULL
site	NULL
;	NULL
MP2	NULL
,	NULL
second	NULL
mutant	NULL
oligonucleotide	NULL
of	NULL
the	NULL
PuF	NULL
site	NULL
;	NULL
MP3	NULL
,	NULL
double	NULL
mutant	NULL
oligonucleotide	NULL
of	NULL
the	NULL
PuF	NULL
site	NULL
.	NULL

The	NULL
EMSA	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
PuF	NULL
probes	NULL
and	NULL
nuclear	NULL
extract	NULL
are	NULL
labeled	NULL
C1I-C4	NULL
and	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
ar-rows	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
with	NULL
the	NULL
mutated	NULL
PuF	NULL
oligonucleotides	NULL
as	NULL
probes	NULL
and	NULL
the	NULL
wild	NULL
type	NULL
PuF	NULL
DNA	NULL
fragment	NULL
or	NULL
oligonucleotide	NULL
as	NULL
competitors	NULL
.	NULL

The	NULL
lanes	NULL
are	NULL
labeled	NULL
as	NULL
described	NULL
above	NULL
for	NULL
panel	NULL
A.	NULL
c-mye	NULL
promoter	NULL
activity	NULL
by	NULL
approximately	NULL
65	NULL
%	NULL
in	NULL
DHL-9	NULL
and	NULL
Raji	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
both	NULL
the	NULL
5'-	NULL
and	NULL
3'-halves	NULL
of	NULL
the	NULL
sites	NULL
simultaneously	NULL
led	NULL
to	NULL
a	NULL
drop	NULL
in	NULL
activity	NULL
of	NULL
approximately	NULL
75	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
a	NULL
50-bp	NULL
region	NULL
of	NULL
the	NULL
c-myc	NULL
promoter	NULL
,	NULL
which	NULL
encompasses	NULL
the	NULL
PuF	NULL
site	NULL
(	NULL
-148	NULL
to	NULL
-98	NULL
,	NULL
DMC1	NULL
mutant	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
activity	NULL
of	NULL
approximately	NULL
85	NULL
%	NULL
in	NULL
both	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
-148	NULL
construct	NULL
(	NULL
DMC2	NULL
mutant	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
PuF	NULL
site	NULL
is	NULL
active	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
vivo	NULL
footprinting	NULL
has	NULL
been	NULL
used	NULL
to	NULL
identify	NULL
a	NULL
region	NULL
near	NULL
DNase	NULL
hypersensitive	NULL
site	NULL
III-1	NULL
,	NULL
which	NULL
is	NULL
protected	NULL
on	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

The	NULL
normal	NULL
e-mye	NULL
allele	NULL
,	NULL
which	NULL
is	NULL
transcriptionally	NULL
silent	NULL
,	NULL
does	NULL
not	NULL
show	NULL
any	NULL
protection	NULL
in	NULL
this	NULL
area	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
by	NULL
several	NULL
different	NULL
techniques	NULL
that	NULL
Nm23H2	NULL
in	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
binds	NULL
to	NULL
this	NULL
sequence	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
PuF	NULL
transcription	NULL
factor	NULL
was	NULL
originally	NULL
identified	NULL
and	NULL
purified	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

PuF	NULL
was	NULL
subsequently	NULL
shown	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
Nm23H2	NULL
(	NULL
37	NULL
)	NULL
.	NULL

An	NULL
antibody	NULL
against	NULL
Nm23H1/Nm23H2	NULL
disrupted	NULL
the	NULL
complexes	NULL
formed	NULL
in	NULL
EMSA	NULL
with	NULL
both	NULL
the	NULL
F50	NULL
probe	NULL
and	NULL
the	NULL
PuF	NULL
oligonucleotide	NULL
.	NULL

No	NULL
supershifted	NULL
complex	NULL
was	NULL
visible	NULL
;	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
antibody	NULL
blocks	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
Nm23H2	NULL
.	NULL

Both	NULL
preimmune	NULL
serum	NULL
and	NULL
an	NULL
antibody	NULL
against	NULL
Ets-1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
EMSA	NULL
complexes	NULL
.	NULL

A	NULL
protein	NULL
of	NULL
molecular	NULL
mass	NULL
17	NULL
kDa	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
both	NULL
the	NULL
F50	NULL
probe	NULL
and	NULL
the	NULL
PuF	NULL
oligonucleotide	NULL
;	NULL
this	NULL
is	NULL
the	NULL
size	NULL
of	NULL
Nm23H2	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Western	NULL
analysis	NULL
revealed	NULL
that	NULL
this	NULL
protein	NULL
was	NULL
recognized	NULL
by	NULL
the	NULL
Nm23H1/Nm23H2	NULL
antibody	NULL
.	NULL

Methylation	NULL
interference	NULL
revealed	NULL
that	NULL
the	NULL
guanine	NULL
residues	NULL
in	NULL
the	NULL
PuF	NULL
sequence	NULL
were	NULL
required	NULL
for	NULL
protein	NULL
binding	NULL
,	NULL
and	NULL
the	NULL
footprint	NULL
was	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
we	NULL
obtained	NULL
in	NULL
vivo	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
why	NULL
only	NULL
guanine	NULL
residues	NULL
in	NULL
the	NULL
3'-half	NULL
of	NULL
the	NULL
PuF	NULL
site	NULL
interfere	NULL
with	NULL
binding	NULL
in	NULL
vitro	NULL
with	NULL
the	NULL
F50	NULL
probe	NULL
.	NULL

Differences	NULL
in	NULL
secondary	NULL
structure	NULL
between	NULL
the	NULL
longer	NULL
fragment	NULL
and	NULL
the	NULL
shorter	NULL
oligonucleotide	NULL
may	NULL
be	NULL
involved	NULL
.	NULL

EMSA	NULL
with	NULL
the	NULL
PuF	NULL
oligonucleotide	NULL
yielded	NULL
three	NULL
complexes	NULL
,	NULL
and	NULL
only	NULL
complex	NULL
C2	NULL
contained	NULL
Nm23H2	NULL
protein	NULL
.	NULL

A	NULL
single	NULL
complex	NULL
with	NULL
Nm23H2	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
50-bp	NULL
fragment	NULL
.	NULL

Differences	NULL
in	NULL
protein	NULL
binding	NULL
between	NULL
longer	NULL
DNA	NULL
fragments	NULL
and	NULL
shorter	NULL
oligonucleotides	NULL
has	NULL
been	NULL
observed	NULL
previously	NULL
for	NULL
the	NULL
PuF	NULL
factor	NULL
(	NULL
38	NULL
)	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
PuF	NULL
site	NULL
has	NULL
functional	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
half	NULL
of	NULL
the	NULL
site	NULL
led	NULL
to	NULL
a	NULL
0	NULL
FSO	NULL
MP1	NULL
MP2	NULL
MP3	NULL
0	NULL
PUF	NULL
MP1	NULL
MP2	NULL
MP3	NULL
13397	NULL
B	NULL
PUF	NULL
Probe	NULL
MP1	NULL
Probe	NULL
MP2	NULL
Probe	NULL
MP3	NULL
Probe	NULL
Js	NULL
t	NULL
im	NULL
-a	NULL
i	NULL
>	NULL
<	NULL
--	NULL
-	NULL
»	NULL
0	NULL
Eso	NULL
PUF	NULL
0	NULL
FS0o	NULL
PUF	NULL
0	NULL
FSO	NULL
PUF	NULL
wis	NULL
u	NULL
»	NULL
,	NULL
H	NULL
M	NULL
MB	NULL
_	NULL
..	NULL
,	NULL
«	NULL
»	NULL
#	NULL
--	NULL
=	NULL
60	NULL
7	NULL
8s	NULL
9	NULL
10	NULL
10	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
70	NULL
8	NULL
9	NULL
drop	NULL
in	NULL
e-mye	NULL
promoter	NULL
activity	NULL
of	NULL
approximately	NULL
55-65	NULL
%	NULL
.	NULL

Mutations	NULL
of	NULL
both	NULL
halves	NULL
simultaneously	NULL
decreased	NULL
promoter	NULL
activity	NULL
by	NULL
75	NULL
%	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
region	NULL
also	NULL
caused	NULL
a	NULL
dramatic	NULL
decrease	NULL
in	NULL
activity	NULL
(	NULL
approximately	NULL
85	NULL
%	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
observed	NULL
an	NULL
in	NULL
vivo	NULL
footprint	NULL
over	NULL
the	NULL
PuF	NULL
site	NULL
in	NULL
proliferating	NULL
HL60	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
.	NULL

This	NULL
footprint	NULL
was	NULL
not	NULL
present	NULL
in	NULL
differentiated	NULL
HL60	NULL
cells	NULL
that	NULL
no	NULL
longer	NULL
expressed	NULL
c-myc	NULL
.	NULL

Our	NULL
results	NULL
in	NULL
B	NULL
cells	NULL
demonstrate	NULL
that	NULL
this	NULL
site	NULL
functions	NULL
as	NULL
a	NULL
positive	NULL
regulatory	NULL
region	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
findings	NULL
in	NULL
HL60	NULL
cells	NULL
,	NULL
although	NULL
there	NULL
is	NULL
currently	NULL
no	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
the	NULL
PuF	NULL
site	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
retention	NULL
or	NULL
read-through	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
at	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
PuF	NULL
site	NULL
functions	NULL
as	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
it	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

This	NULL
site	NULL
is	NULL
unoccupied	NULL
in	NULL
the	NULL
normal	NULL
e-myc	NULL
allele	NULL
.	NULL

Previously	NULL
identified	NULL
differences	NULL
in	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
between	NULL
the	NULL
two	NULL
e-myc	NULL
alleles	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
have	NULL
been	NULL
described	NULL
(	NULL
54-56	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
is	NULL
the	NULL
absence	NULL
of	NULL
DNase	NULL
hypersensitive	NULL
site	NULL
III-1	NULL
in	NULL
the	NULL
normal	NULL
c-myc	NULL
allele	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
chromatin	NULL
conformation	NULL
is	NULL
different	NULL
in	NULL
each	NULL
allele	NULL
,	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
conformation	NULL
of	NULL
the	NULL
normal	NULL
allele	NULL
prevents	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
PuF	NULL
site	NULL
located	NULL
close	NULL
to	NULL
DNase	NULL
hypersensitive	NULL
site	NULL
III-1	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
differences	NULL
in	NULL
methylation	NULL
of	NULL
the	NULL
two	NULL
e-mye	NULL
alleles	NULL
account	NULL
for	NULL
the	NULL
differential	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
PuF	NULL
site	NULL
,	NULL
which	NULL
we	NULL
have	NULL
observed	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
deregulation	NULL
of	NULL
the	NULL
translocated	NULL
e-mye	NULL
allele	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
interactions	NULL
between	NULL
the	NULL
c-myc	NULL
promoter	NULL
region	NULL
and	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
immunoglobulin	NULL
locus	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
identified	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
c-mye	NULL
promoter	NULL
that	NULL
are	NULL
occupied	NULL
only	NULL
on	NULL
the	NULL
translocated	NULL
allele	NULL
and	NULL
that	NULL
function	NULL
as	NULL
positive	NULL
regulatory	NULL
elements	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Regulatory	NULL
elements	NULL
in	NULL
both	NULL
the	NULL
human	NULL
immunoglobulin	NULL
x	NULL
locus	NULL
and	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
locus	NULL
have	NULL
been	NULL
described	NULL
that	NULL
lead	NULL
to	NULL
increased	NULL
e-mye	NULL
expression	NULL
and	NULL
the	NULL
shift	NULL
in	NULL
promoter	NULL
usage	NULL
from	NULL
P2	NULL
to	NULL
P1	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
investigating	NULL
the	NULL
interaction	NULL
between	NULL
these	NULL
regulatory	NULL
elements	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
that	NULL
we	NULL
have	NULL
identified	NULL
on	NULL
the	NULL
translocated	NULL
c-myc	NULL
allele	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

13398	NULL
co	NULL
bo	NULL
w	NULL
o	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

REFERENCES	NULL
.	NULL

ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Nishikura	NULL
,	NULL
K.	NULL
,	NULL
Erikson	NULL
,	NULL
J.	NULL
,	NULL
Watt	NULL
,	NULL
R.	NULL
,	NULL
Rovera	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Croce	NULL
,	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Science	NULL
222	NULL
,	NULL
390-393	NULL
.	NULL

Cory	NULL
,	NULL
S.	NULL
(	NULL
1986	NULL
)	NULL
Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47	NULL
,	NULL
189-234	NULL
.	NULL

Hayday	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Gillies	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Saito	NULL
,	NULL
H.	NULL
,	NULL
Wood	NULL
,	NULL
C.	NULL
,	NULL
Wiman	NULL
,	NULL
D.	NULL
,	NULL
Hayward	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
Tonegawa	NULL
,	NULL
S.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
807	NULL
,	NULL
334-340	NULL
.	NULL

Nishikura	NULL
,	NULL
K.	NULL
,	NULL
ar-Rushdi	NULL
,	NULL
A.	NULL
,	NULL
Erikson	NULL
,	NULL
J.	NULL
,	NULL
Watt	NULL
,	NULL
R.	NULL
,	NULL
Rovera	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

80	NULL
,	NULL
4822-4826	NULL
.	NULL

Cesarman	NULL
,	NULL
E.	NULL
,	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
,	NULL
Bentley	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
298	NULL
,	NULL
1272-1275	NULL
.	NULL

Pelicci	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Magrath	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
2984-2988	NULL
.	NULL

Yu	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Ichinose	NULL
,	NULL
I.	NULL
,	NULL
Bonham	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Zajac-Kaye	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
19586-19592	NULL
.	NULL

Zajac-Kaye	NULL
,	NULL
M.	NULL
,	NULL
Gelmann	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
and	NULL
Levens	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
1776-1780	NULL
.	NULL

Battey	NULL
,	NULL
J.	NULL
,	NULL
Moulding	NULL
,	NULL
C.	NULL
,	NULL
Taub	NULL
,	NULL
R.	NULL
,	NULL
Murphy	NULL
,	NULL
W.	NULL
,	NULL
Stewart	NULL
,	NULL
T.	NULL
,	NULL
Potter	NULL
,	NULL
H.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
84	NULL
,	NULL
779-787	NULL
Taub	NULL
,	NULL
R.	NULL
,	NULL
Moulding	NULL
,	NULL
C.	NULL
,	NULL
Battey	NULL
,	NULL
J.	NULL
,	NULL
Murphy	NULL
,	NULL
W.	NULL
,	NULL
Vasicek	NULL
,	NULL
T.	NULL
,	NULL
Lenoir	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
86	NULL
,	NULL
339-348	NULL
Bentley	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
821	NULL
,	NULL
702-706	NULL
Eick	NULL
,	NULL
D.	NULL
,	NULL
Polack	NULL
,	NULL
A.	NULL
,	NULL
Kofler	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Bornkamm	NULL
,	NULL
G.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Oncogene	NULL
3	NULL
,	NULL
397-403	NULL
Nepveu	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Marcu	NULL
,	NULL
K.	NULL
B	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

5	NULL
,	NULL
2859-2865	NULL
Adams	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Harris	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Pinkert	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Alexander	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Cory	NULL
,	NULL
S.	NULL
,	NULL
Palmiter	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Brinster	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
318	NULL
,	NULL
533-538	NULL
Nussenzweig	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Schmidt	NULL
,	NULL
E.	NULL
,	NULL
Shaw	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Sinn	NULL
,	NULL
E.	NULL
,	NULL
Campos-Torres	NULL
,	NULL
J.	NULL
,	NULL
Mathey-Prevot	NULL
,	NULL
B.	NULL
,	NULL
Pattengale	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
386	NULL
,	NULL
446-450	NULL
Lombardi	NULL
,	NULL
L.	NULL
,	NULL
Newcomb	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
161-170	NULL
Madisen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
2212-2226	NULL
Polack	NULL
,	NULL
A.	NULL
,	NULL
Feederle	NULL
,	NULL
R.	NULL
,	NULL
Klobeck	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hortnagel	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3913-3920	NULL
Ji	NULL
,	NULL
L.	NULL
,	NULL
Arcinas	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Boxer	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7967-7974	NULL
Bevilacqua	NULL
,	NULL
G.	NULL
,	NULL
Sobel	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Liotta	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

49	NULL
,	NULL
5185-5190	NULL
Florenes	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Aamdal	NULL
,	NULL
S.	NULL
,	NULL
Myklebost	NULL
,	NULL
O.	NULL
,	NULL
Maelandsmo	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Bruland	NULL
,	NULL
O.	NULL
S.	NULL
,	NULL
and	NULL
Fodstad	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

52	NULL
,	NULL
6088-6091	NULL
Nakayama	NULL
,	NULL
T.	NULL
,	NULL
Ohtsuru	NULL
,	NULL
A.	NULL
,	NULL
Nakao	NULL
,	NULL
K.	NULL
,	NULL
Shima	NULL
,	NULL
M.	NULL
,	NULL
Nakata	NULL
,	NULL
K.	NULL
,	NULL
Watanabe	NULL
,	NULL
K.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Kimura	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Nagataki	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

84	NULL
,	NULL
1349-1354	NULL
Hirayama	NULL
,	NULL
R.	NULL
,	NULL
Sawai	NULL
,	NULL
S.	NULL
,	NULL
Takagi	NULL
,	NULL
Y.	NULL
,	NULL
Mishima	NULL
,	NULL
Y.	NULL
,	NULL
Kimura	NULL
,	NULL
N.	NULL
,	NULL
Shimada	NULL
,	NULL
N.	NULL
,	NULL
Esaki	NULL
,	NULL
Y.	NULL
,	NULL
Kurashima	NULL
,	NULL
C.	NULL
,	NULL
Utsuyama	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hirokawa	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

88	NULL
,	NULL
1249-1250	NULL
Engel	NULL
,	NULL
M.	NULL
,	NULL
Theisinger	NULL
,	NULL
B.	NULL
,	NULL
Seib	NULL
,	NULL
T.	NULL
,	NULL
Seitz	NULL
,	NULL
G.	NULL
,	NULL
Huwer	NULL
,	NULL
H.	NULL
,	NULL
Zang	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Welter	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Dooley	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
55	NULL
,	NULL
375-379	NULL
Hailat	NULL
,	NULL
N.	NULL
,	NULL
Keim	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Melhem	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Zhu	NULL
,	NULL
X.	NULL
X.	NULL
,	NULL
Eckerskorn	NULL
,	NULL
C.	NULL
,	NULL
Brodeur	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Reynolds	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
Seeger	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Strahler	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Hanash	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
341-345	NULL
Haut	NULL
,	NULL
M.	NULL
,	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Willson	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Markowitz	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

88	NULL
,	NULL
712-716	NULL
Leone	NULL
,	NULL
A.	NULL
,	NULL
Flatow	NULL
,	NULL
U.	NULL
,	NULL
VanHoutte	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
2325-2333	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

Nm23H2	NULL
Binds	NULL
to	NULL
the	NULL
Translocated	NULL
c-myc	NULL
Allele	NULL
28	NULL
.	NULL

29	NULL
.	NULL

Myeroff	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
and	NULL
Markowitz	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

85	NULL
,	NULL
147-152	NULL
Keim	NULL
,	NULL
D.	NULL
,	NULL
Hailat	NULL
,	NULL
N.	NULL
,	NULL
Melhem	NULL
,	NULL
R.	NULL
,	NULL
Zhu	NULL
,	NULL
X.	NULL
X.	NULL
,	NULL
Lascu	NULL
,	NULL
L.	NULL
,	NULL
Veron	NULL
,	NULL
M.	NULL
,	NULL
Strahler	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hanash	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89	NULL
,	NULL
919-924	NULL
Lakso	NULL
,	NULL
M.	NULL
,	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Westphal	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
Growth	NULL
&	NULL
Differ	NULL
.	NULL

8	NULL
,	NULL
873-879	NULL
Okabe-Kado	NULL
,	NULL
J.	NULL
,	NULL
Kasukabe	NULL
,	NULL
T.	NULL
,	NULL
Honma	NULL
,	NULL
Y.	NULL
,	NULL
Hayashi	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Hozumi	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
10994-10999	NULL
Biggs	NULL
,	NULL
J.	NULL
,	NULL
Hersperger	NULL
,	NULL
E.	NULL
,	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Liotta	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Shearn	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
933-940	NULL
Gilles	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Presecan	NULL
,	NULL
E.	NULL
,	NULL
Vonica	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Lascu	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8784-8789	NULL
Lacombe	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Sastre-Garau	NULL
,	NULL
X.	NULL
,	NULL
Lascu	NULL
,	NULL
I.	NULL
,	NULL
Vonica	NULL
,	NULL
A.	NULL
,	NULL
Wallet	NULL
,	NULL
V.	NULL
,	NULL
Thiery	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Veron	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
27	NULL
,	NULL
1802-1307	NULL
Wallet	NULL
,	NULL
V.	NULL
,	NULL
Mutzel	NULL
,	NULL
R.	NULL
,	NULL
Troll	NULL
,	NULL
H.	NULL
,	NULL
Barzu	NULL
,	NULL
O.	NULL
,	NULL
Wurster	NULL
,	NULL
B.	NULL
,	NULL
Veron	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Lacombe	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

82	NULL
,	NULL
1199-1202	NULL
Bominaar	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Molijn	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Pestel	NULL
,	NULL
M.	NULL
,	NULL
Veron	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Van	NULL
Haastert	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2275-2279	NULL
Postel	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Berberich	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Flint	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Ferrone	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
478-480	NULL
Postel	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Mango	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Flint	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5123-5133	NULL
Postel	NULL
,	NULL
E.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Ann	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

660	NULL
,	NULL
57-63	NULL
Postel	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
and	NULL
Ferrone	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
8627-8630	NULL
Avigan	NULL
,	NULL
M.	NULL
L	NULL
,	NULL
Strober	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Levens	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
18538-18545	NULL
Higuchi	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
PCR	NULL
Protocols	NULL
:	NULL
A	NULL
Guide	NULL
to	NULL
Methods	NULL
and	NULL
Applications	NULL
(	NULL
Innis	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Gelfand	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Sninsky	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

177-183	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
San	NULL
Diego	NULL
Arcinas	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Boxer	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
2699-2706	NULL
Arcinas	NULL
,	NULL
M.	NULL
,	NULL
Sizer	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
and	NULL
Boxer	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
21919-21924	NULL
Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

65	NULL
,	NULL
499-560	NULL
Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
780-786	NULL
Pfeifer	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Steigerwald	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
Wold	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Riggs	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
810-813	NULL
Garrity	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
1021-1025	NULL
Chodosh	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
in	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
(	NULL
Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Struble	NULL
,	NULL
K.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

12.5.1-12.5.6	NULL
,	NULL
Green	NULL
Publishing	NULL
and	NULL
Wiley-Inter-science	NULL
,	NULL
New	NULL
York	NULL
Gauss	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
and	NULL
Lieber	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
6739-6740	NULL
Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1978	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
Krumm	NULL
,	NULL
A.	NULL
,	NULL
Meulia	NULL
,	NULL
T.	NULL
,	NULL
Brunvand	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
2201-2213	NULL
Strobl	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Eick	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3307-3314	NULL
Dyson	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Littlewood	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Forster	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
2885-2891	NULL
Dyson	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
1984-1988	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Hennighausen	NULL
,	NULL
L.	NULL
,	NULL
Battey	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
37	NULL
,	NULL
381-391	NULL

